PLEASANTON, Calif. –  NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced that the European Association of Urology (EAU) has given the UroLift® System a positive recommendation for the treatment of patients with benign prostatic hyperplasia (BPH) in its newly updated “Guidelines for the Management of NonNeurogenic Male Lower Urinary Tract Symptoms, Including Benign Prostatic Obstruction,” published in European Urology.
The guidelines assist practicing urologists in Europe in making informed decisions based on the highest-quality scientific data. … Continue reading NeoTract Announces Positive Guidelines from European Association of Urology for Minimally Invasive Treatment for Benign Prostatic Hyperplasia